Furan-2-yl(piperazin-1-yl)methanone hydrochloride

Catalog No. :
ACBMFR721
CAS No. :
60548-09-6
Molecular Formula :
C9H13ClN2O2
Molecular Weight :
216.67

IUPAC Name:furan-2-yl(piperazin-1-yl)methanone hydrochloride

Furan-2-yl(piperazin-1-yl)methanone hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$56.00Login to see priceIn stockInquiry
100g95%$204.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFuran-2-yl(piperazin-1-yl)methanone hydrochloride
IUPAC Namefuran-2-yl(piperazin-1-yl)methanone hydrochloride
MDL No.MFCD00236012
Molecular FormulaC9H13ClN2O2
Molecular Weight216.67
SMILESO=C(C1=CC=CO1)N2CCNCC2.[H]Cl
InChI KeyFMFUHCXDFVDINI-UHFFFAOYSA-N
SynonymA8443 | DTXSID20484843 | F17041 | 2-Furyl(1-piperazinyl)methanone hydrochloride (1:1) | N-(2-Furoyl)piperazineHydrochloride | 1-(2-Furanylcarbonyl)piperazine HCl | 2-FURYL(1-PIPERAZINYL)METHANONE HYDROCHLORIDE | AI3-36097 | F3146-0171 | AS-10787 | 1-(2-Fu
CAS No.60548-09-6
PubChem CID12289910

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACBMFR721 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBMFR721 route product structure diagram
    ACBMFR72160548-09-6 In Stock
Inquiry

2. ACBMFR721 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBMFR721 route product structure diagram
    ACBMFR72160548-09-6 In Stock
Inquiry

Comments (0)